Webinar | August 9, 2017

What’s New on Section 101 Jurisprudence

  • post-grant-review1
  • life-sciences-research
  • patent-litigation
Share

In this webinar, the panel, including Brooks Kuhsman Shareholder David Randall, discussed updates on patent eligible subject matter since the Alice Bank, Enfish, Mayo Collaborative, and Sequenom v. Ariosa line of cases. They covered case law from federal courts, decisions from the PTAB, results of the USPTO’s roundtables last year on Section 101, as well as recent recommendations from trade associations such as IPO and AIPLA on proposals for legislation change. The panel also discussed the effect of current Section 101 jurisprudence on the technology, software, and biotechnology/biologics industries, and whether the laws as applied in the U.S. are consistent with our obligations under certain international treaties.

 

Releated Webinars

Webinar

Saving Money on Patent Prosecution: How Data-Driven Modeling Lets You Cut With a…

Listen

Webinar

Best Practices for Managing Your Company’s Trade Secrets

Listen

Webinar

Cybersecurity Insights and Trends for Small Businesses

Listen

Webinar

2020 Cybersecurity and Data Privacy Year in Review

Listen

Webinar

PTAB Year in Review: New Designated Decisions and Procedures Impact AIA Trial Strategies

Listen

Webinar

Cybersecurity and Data Privacy Year in Review: Major Breaches, Changes in the Law,…

Listen

Webinar

PTAB Year in Review – Designated Decisions, Constitutional Challenges, and AIA Procedures

Listen

Webinar

Year in Review: 2019 Intellectual Property Litigation

Listen

Webinar

Technology Licensing Basics – What You Need to Know

Listen

Webinar

The New Frontier: Design Patent Protection in the United States

Listen